Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Graphite Bio Announces Participation in Evercore ISI 5th Annual HealthCONx Conference


Graphite Bio, Inc. (Nasdaq: GRPH), a clinical-stage, next-generation gene editing company harnessing the power of high-efficiency precision gene repair to develop therapies with the potential to treat or cure serious diseases, today announced that members of the management team will participate in a fireside chat at the Evercore ISI 5th Annual HealthCONx Conference on Thursday, Dec. 1, 2022, at 11:45 a.m. ET.

The fireside chat will be webcast live from Graphite Bio's website at www.graphitebio.com in the Investors section. A replay of the webcast will be archived and available following the event.

About Graphite Bio

Graphite Bio is a clinical-stage, next-generation gene editing company driven to discover and develop cures for a wide range of serious and life-threatening diseases. The company is pioneering a precision gene editing approach that has the potential to transform human health by achieving one of medicine's most elusive goals: to precisely "find & replace" any gene in the genome. Graphite Bio's UltraHDRtm gene editing platform takes CRISPR beyond cutting and harnesses the power of high-efficiency precision DNA repair, also known as homology directed repair (HDR), to precisely correct genetic mutations, replace entire disease-causing genes with functional genes or insert new genes into predetermined, safe locations. The company was co-founded by academic pioneers in the fields of gene editing and gene therapy, including Maria Grazia Roncarolo, M.D., and Matthew Porteus, M.D., Ph.D.

Learn more about Graphite Bio by visiting www.graphitebio.com and following the company on LinkedIn and Twitter.


These press releases may also interest you

at 11:50
Family Care Center Launches Tampa Clinic, Making Integrated Mental Health Care More Accessible
Family Care Center, one of the nation's premier mental health providers, is expanding with a new outpatient clinic in Tampa, making integrated mental health care more accessible to individuals, couples, families and Veterans in Hillsborough County....

at 11:45
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
Vertex Pharmaceuticals today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following...

at 11:45
Prostate Cancer Summit: Unveiling the Latest Strategies to Beat Prostate Cancer
Free Virtual Summit Brings Together Experts to Revolutionize Prostate Cancer Care and Treatment Key Takeaways: The Prostate Cancer Summit is a premier virtual event that aims to empower men with practical knowledge and strategies in their fight...

at 11:15
Variantyx Secures $36M Investment As Testing Demand And Market Share Continues To Increase
Variantyx, a leader in molecular diagnostics, announced today that it has secured an additional $36 million in funding from its portfolio of investors which includes Peregrine Ventures, Pitango HealthTech, New Era Capital Partners and Bosch Ventures....

at 11:03
Vajra Coffee Offers Chemical Free Naturally Decaffeinated Coffee
The heart of Vajra Coffee's natural decaffeination process lies in its adoption of the Swiss Water® Process, a natural method that removes 99% of caffeine...

at 11:00
United Imaging Healthcare Releases 2023 ESG Report, Advancing Mission of Equal Healthcare for Alltm
United Imaging Healthcare (SSE:688271) has published its 2023 Environment, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. This report highlights the company's advancements in corporate responsibility,...

More news about Health...


News published on and distributed by: